Oncogenes like MYC and RAS and tumor suppressors like TP53 and PTEN are frequently mutated in cancers and play crucial roles in metabolic adaptation, even metabolic rewiring (also often referred as metabolic reprogramming), if the outcome becomes irreversible. This evidence concerns the gene TP53 and cancer.